meta|Evidence - COVID-19
Member of the meta|Evidence galaxy
Treament | Trials | auto | |||
---|---|---|---|---|---|
deaths | viral clearance | hospitalization or death | |||
|
1 / 2 | - | - | - | |
|
0 | - | - | - | |
|
0 | - | - | - | |
|
0 | - | - | - | |
|
0 | - | - | - | |
|
0 | - | - | - | |
|
0 | - | - | - | |
|
1 | - | - | ||
|
0 | - | - | - | |
|
0 | - | - | - | |
|
0 | - | - | - | |
|
0 | - | - | - | |
|
0 | - | - | - |
Statistically conclusive: statistically significant with a strict control of overall risk of type 1 error (statistically demonstrated), does not take into account the risk of bias; suggested: nominally statistically significant but without a strict control of overall risk of type 1 error; inconclusive: not nominally statistically significant
149
treatments |
718
studies with results |
1743
studies screend |
1629
references |
This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N), Université de Lyon (UdL/Idex), and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.
- About - Our approach - Credits - RSS Made with in Lyon - Contact us - Privacy policy -